NSE · FISCHER
Fischer Medical Venture Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹1 Cr with net profit ₹-3 Cr — a -486.11% net margin, versus 10.04% the period before.
Shareholding
As of 2026-09-30
- Promoter63.09%
- Public30.2%
- FII6.71%
25,676 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 4.55× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Trading · ranked #44 of 688 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Adani Enterprises Limited | ₹3,71,625 Cr | 103.62 | 3.78 | 3.66% | 4.59% |
| Avenue Supermarts Limited | ₹2,23,416 Cr | 71.68 | 8.56 | 11.94% | 4.2% |
| Trent Ltd. | ₹1,64,182 Cr | 85.72 | 21.1 | 24.4% | 8.62% |
| FSN E-Commerce Ventures Ltd. | ₹1,01,123 Cr | 304.31 | 60.95 | 19.49% | 2.85% |
| Aditya Infotech Limited | ₹50,682 Cr | 106.18 | 13.81 | 16.16% | 10.38% |
| Vishal Mega Mart Limited | ₹44,037 Cr | 48.96 | 5.58 | 11.37% | 6.45% |
| Premier Energies Limited | ₹40,402 Cr | 22.83 | 7.85 | 34.23% | 19.11% |
| Aegis Logistics Limited | ₹40,053 Cr | 30.06 | 6.01 | 20.01% | 14.99% |
| Redington Limited | ₹25,603 Cr | 12.76 | 2.38 | 18.62% | 1.31% |
| Honasa Consumer Limited | ₹15,206 Cr | 60.26 | 10.75 | 19.03% | 10.3% |
| Fischer Medical Venture Limited(this company) | ₹1,698 Cr | 69.43 | 3.48 | 8.06% | 6.67% |
AI analysis
AI-generated · google/gemini-2.5-flashFischer Medical Venture Limited is listed with a market capitalization of Rs 2613 Cr. The company reported revenue of Rs 112.19 Cr and a profit margin of 10.06%. The 52-week high for the share price was Rs 124.7 and the 52-week low was Rs 31.05.
Positives
- +Revenue growth was 427.6%, reaching Rs 112.19 Cr.
- +The debt-to-equity ratio is low at 0.21.
- +The promoter holding is substantial at 62.15% as of June 30, 2026.
Negatives
- −The latest reported quarterly net profit for March 2026 was negative at Rs -7.1 Cr.
- −Promoters have pledged 7.38% of their shares as of June 30, 2026.
- −The company has a high PE ratio of 84.94.
- −The dividend yield is high at 13%, which may indicate unsustainable dividend payouts relative to earnings or a share price decline.
Financial performance
The company's revenue grew by 427.6% to Rs 112.19 Cr. For the quarter ending March 2026, revenue stood at Rs 97.73 Cr with a net profit of Rs -7.1 Cr. In the preceding quarter (December 2025), revenue was Rs 101.1 Cr with a net profit of Rs 19.23 Cr.
Profitability & returns
Fischer Medical Venture Limited posted a profit margin of 10.06%. The Return on Equity (ROE) was 8.06%, and the Return on Capital Employed (ROCE) was 10.66%. The Earnings Per Share (EPS) for the latest period was Rs 0.47.
Balance sheet
The company maintains a debt-to-equity ratio of 0.21. The book value per share is Rs 5.88. No further specific balance sheet items are available in the provided data.
Ownership & pledges
As of June 30, 2026, promoters held 62.15% of the shares. Institutions held 6.83% of the shares, comprising 1.35% by DIIs and 5.48% by FIIs. Public shareholding was 31.02%. Promoters have pledged 7.38% of their shares.
Data as of — price: 2026-11-07 · financials: Jun 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Fischer Medical Venture Limitedshare price & fundamentals